Source comparison
ARA-290 vs BPC-157: Research Comparison
Primary Mechanism Tissue-protective receptor agonist. Reduces inflammatory cytokine release via JAK2/STAT3 Growth factor modulation. Upregulates VEGF, FGF, stabilizes growth hormone at injury sites ARA-290 for systemic inflammation; BPC-157 for localized tissu
This comparison does not assign a generated winner or score.
- Primary Mechanism
- Tissue-protective receptor agonist. Reduces inflammatory cytokine release via JAK2/STAT3
- Growth factor modulation. Upregulates VEGF, FGF, stabilizes growth hormone at injury sites
- ARA-290 for systemic inflammation; BPC-157 for localized tissue growth
- Half-Life
- 5–8 hours
- Not definitively established (estimated 4–6 hours based on bioactivity duration)
- ARA-290 requires more frequent dosing for sustained effect
- Optimal Application Window
- Acute phase (0–72 hours post-injury)
- Subacute to chronic phase (3 days to several weeks post-injury)
- ARA-290 frontloaded; BPC-157 effective later in healing timeline
- Tissue Specificity
- Neural, cardiac, endothelial, renal
- Musculoskeletal, gastrointestinal, vascular
- BPC-157 shows broader tissue applicability in published studies
- Regulatory Status
- Patented compound with phase II human trial data
- Research-only compound, no human clinical data
- ARA-290 easier to justify in IRB protocols requiring prior safety data
- Typical Research Dose
- 1–4 mg per dose (0.015–0.06 mg/kg in rodents)
- 10–500 mcg per dose (0.01–5 mcg/g body weight in rodents)
- BPC-157 effective at significantly lower absolute doses
- Bottom Line
- Choose ARA-290 when studying systemic inflammatory suppression, neuroprotection, or ischemia-reperfusion models where new tissue formation is not the primary goal
- Choose BPC-157 when studying wound healing, tendon repair, angiogenesis, or gastrointestinal mucosal recovery where localized tissue regeneration is the endpoint
- The ara-290 vs bpc-157 which better comparison is mechanism-dependent. Both are effective, but in fundamentally different injury contexts